A forward genetics platform for papillomavirus research
- 1Department of Genetics, Yale School of Medicine, New Haven, CT, USA.
Abstract
The inability to perform forward genetics has been a major barrier to human papillomavirus (HPV) research. Here, we report a platform for phenotypic selection of HPV mutants. Our method relies on large "concordant" virus libraries, where each mutant virus particle encapsidates the mutant plasmid that encodes it, thereby directly linking viral genotype to phenotype. This platform can achieve a ∼2500-fold enrichment of an L1 capsid protein mutant from an excess of wild-type virus. To demonstrate that this system could select rare mutants from complex libraries, we selected and validated antibody escape mutants and showed that two neutralizing antibodies that recognize overlapping epitopes in L1 display distinct patterns of HPV recognition. This genetics approach unlocks previously inaccessible avenues of investigation into the HPV life cycle and provides a powerful engine to develop improved vaccines and novel antiviral strategies.
Related
- Forward genetics reveals a conserved CNBHD-CNBHD interface that restrains EAG channel activation to regulate sleep
- A History of Cancer Research: Mouse Models of Cancer Genetics
- Pragmatic water and health research in a complex emergency: Learnings and way forward
- Visualizing α‐synuclein pathology in live brain: A new platform for Parkinson's disease research
- Research on resource sharing and allocation incentive mechanism of new energy vehicle charging cloud platform
BibTeX
@article{takeo2026forward,
title = {{A forward genetics platform for papillomavirus research}},
author = {Yuka Takeo and Sydney R. Hirsch and Daniel DiMaio},
journal = {Science Advances},
year = {2026},
month = oct,
doi = {10.1126/sciadv.aei3417},
url = {https://www.science.org/doi/10.1126/sciadv.aei3417},
note = {CC BY-NC},
}
RIS
TY - JOUR
TI - A forward genetics platform for papillomavirus research
AU - Yuka Takeo
AU - Sydney R. Hirsch
AU - Daniel DiMaio
PY - 2026
DA - 2026/10/02
JO - Science Advances
DO - 10.1126/sciadv.aei3417
UR - https://www.science.org/doi/10.1126/sciadv.aei3417
AB - The inability to perform forward genetics has been a major barrier to human papillomavirus (HPV) research. Here, we report a platform for phenotypic selection of HPV mutants. Our method relies on large "concordant" virus libraries, where each mutant virus particle encapsidates the mutant plasmid that encodes it, thereby directly linking viral genotype to phenotype. This platform can achieve a ∼2500-fold enrichment of an L1 capsid protein mutant from an excess of wild-type virus. To demonstrate that this system could select rare mutants from complex libraries, we selected and validated antibody escape mutants and showed that two neutralizing antibodies that recognize overlapping epitopes in L1 display distinct patterns of HPV recognition. This genetics approach unlocks previously inaccessible avenues of investigation into the HPV life cycle and provides a powerful engine to develop improved vaccines and novel antiviral strategies.
SN - 2375-2548
ER -